Merck
CN
  • C2-symmetric cyclic selenium-catalyzed enantioselective bromoaminocyclization.

C2-symmetric cyclic selenium-catalyzed enantioselective bromoaminocyclization.

Journal of the American Chemical Society (2013-01-15)
Feng Chen, Chong Kiat Tan, Ying-Yeung Yeung
ABSTRACT

A catalytic asymmetric bromocyclization of trisubstituted olefinic amides that uses a C(2)-symmetric mannitol-derived cyclic selenium catalyst and a stoichiometric amount of N-bromophthalimide is reported. The resulting enantioenriched pyrrolidine products, which contain two stereogenic centers, can undergo rearrangement to yield 2,3-disubstituted piperidines with excellent diastereoselectivity and enantiospecificity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Bromophthalimide, 95%